These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 23389968)
1. Nuclear expression of glycogen synthase kinase-3β and lack of membranous β-catenin is correlated with poor survival in colon cancer. Salim T; Sjölander A; Sand-Dejmek J Int J Cancer; 2013 Aug; 133(4):807-15. PubMed ID: 23389968 [TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase-3β does not correlate with the expression and activity of β-catenin in gastric cancer. Cho YJ; Yoon J; Ko YS; Kim SY; Cho SJ; Kim WH; Park JW; Youn HD; Kim JH; Lee BL APMIS; 2010 Oct; 118(10):782-90. PubMed ID: 20854473 [TBL] [Abstract][Full Text] [Related]
3. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity. Song S; Mazurek N; Liu C; Sun Y; Ding QQ; Liu K; Hung MC; Bresalier RS Cancer Res; 2009 Feb; 69(4):1343-9. PubMed ID: 19190323 [TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer. Naito S; Bilim V; Yuuki K; Ugolkov A; Motoyama T; Nagaoka A; Kato T; Tomita Y Clin Cancer Res; 2010 Nov; 16(21):5124-32. PubMed ID: 20889919 [TBL] [Abstract][Full Text] [Related]
5. Apical membrane localization of glycogen synthase kinase 3beta protein in normal colon epithelium and aberrant distribution in colorectal cancer. Hirakawa H; Nakayama T; Shibata K; Mihara Y; Taba M; Nagayasu T; Sekine I Cancer Lett; 2009 Mar; 275(1):158-62. PubMed ID: 19022564 [TBL] [Abstract][Full Text] [Related]
6. Oncogenic function of DACT1 in colon cancer through the regulation of β-catenin. Yuan G; Wang C; Ma C; Chen N; Tian Q; Zhang T; Fu W PLoS One; 2012; 7(3):e34004. PubMed ID: 22470507 [TBL] [Abstract][Full Text] [Related]
7. Regulation of β-catenin nuclear dynamics by GSK-3β involves a LEF-1 positive feedback loop. Jamieson C; Sharma M; Henderson BR Traffic; 2011 Aug; 12(8):983-99. PubMed ID: 21496192 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells. Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211 [TBL] [Abstract][Full Text] [Related]
10. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer. Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872 [TBL] [Abstract][Full Text] [Related]
11. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation. Lu WJ; Chua MS; Wei W; So SK Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353 [TBL] [Abstract][Full Text] [Related]
12. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation. Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223 [TBL] [Abstract][Full Text] [Related]
13. The inflammatory mediator leukotriene D₄ induces subcellular β-catenin translocation and migration of colon cancer cells. Salim T; Sand-Dejmek J; Sjölander A Exp Cell Res; 2014 Feb; 321(2):255-66. PubMed ID: 24211746 [TBL] [Abstract][Full Text] [Related]
14. Nuclear GSK-3beta inhibits the canonical Wnt signalling pathway in a beta-catenin phosphorylation-independent manner. Caspi M; Zilberberg A; Eldar-Finkelman H; Rosin-Arbesfeld R Oncogene; 2008 Jun; 27(25):3546-55. PubMed ID: 18223684 [TBL] [Abstract][Full Text] [Related]
16. Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator. Wang S; Bao Z; Liang QM; Long JW; Xiao ZS; Jiang ZJ; Liu B; Yang J; Long ZX Hepatogastroenterology; 2013 Oct; 60(127):1639-46. PubMed ID: 24634935 [TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3 beta regulates Snail and β-catenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer. Zheng H; Li W; Wang Y; Liu Z; Cai Y; Xie T; Shi M; Wang Z; Jiang B Eur J Cancer; 2013 Aug; 49(12):2734-46. PubMed ID: 23582741 [TBL] [Abstract][Full Text] [Related]
18. Dual alterations in casein kinase I-epsilon and GSK-3beta modulate beta-catenin stability in hyperproliferating colonic epithelia. Umar S; Wang Y; Morris AP; Sellin JH Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G599-607. PubMed ID: 17053159 [TBL] [Abstract][Full Text] [Related]
19. Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization. Neelam S; Brooks MM; Cammarata PR Mol Vis; 2014; 20():1758-75. PubMed ID: 25593505 [TBL] [Abstract][Full Text] [Related]
20. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway. Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]